Discovery Laboratories Inc (NASDAQ:DSCO)

Data as of Oct 21
 +0.01 / +0.52%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Discovery Laboratories, Inc. is engaged in the manufacture and development of products for infants and respiratory diseases. It focuses on producing surfactant replacement therapies for patients with respiratory disease and neonatology for the improvement of respiratory distress syndrome for infants. Its products include SURFAXIN and AFECTAIR. The company was founded in 1992 and is headquartered in Warrington, PA.

Contact Information

Discovery Laboratories, Inc.
2600 Kelly Road
Warrington Pennsylvania 18976-3622
P:(215) 488-9300
Investor Relations:



Other institutional42.01%
Mutual fund holders19.99%
Individual stakeholders0.79%

Top Executives

John G. CooperPresident, CEO, Treasurer & Director
Thomas F. MillerChief Operating Officer & Senior Vice President
John Andrew TattorySenior VP, Chief Financial & Accounting Officer
Robert SegalSenior Vice President-Medical & Scientific Affairs
Russell ClaytonSenior Vice President-Research & Development

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.